Stepped-care to prevent depression and anxiety in visually impaired older adults - design of a randomised controlled trial by van der Aa, Hilde P. A. et al.
van der Aa et al. BMC Psychiatry 2013, 13:209
http://www.biomedcentral.com/1471-244X/13/209STUDY PROTOCOL Open AccessStepped-care to prevent depression and anxiety
in visually impaired older adults – design of a
randomised controlled trial
Hilde PA van der Aa1,2*, Ger HMB van Rens1,2,3, Hannie C Comijs2,4, Judith E Bosmans5, Tom H Margrain6
and Ruth MA van Nispen1,2Abstract
Background: Subthreshold depression and anxiety are common in the growing population of visually impaired
older adults and increase the risk of full-blown depressive or anxiety disorders. Adequate treatment may prevent
the development of depression or anxiety in this high risk group.
Method/design: A stepped-care programme was developed based on other effective interventions and
focus groups with professionals and patient representatives of three low vision rehabilitation organisations
in the Netherlands and Belgium. The final programme consists of four steps: 1) watchful waiting,
2) guided self-help, 3) problem solving treatment, 4) referral to general practitioner. The (cost-)
effectiveness of this programme is evaluated in a randomised controlled trial. Patients (N = 230) are
randomly assigned to either a treatment group (stepped-care) or a control group (usual care). The
primary outcome is the incidence of depressive and anxiety disorders, measured with the Mini
International Neuropsychiatric Interview (MINI).
Discussion: Preventive interventions for depression and anxiety have received little attention in the field
of low vision. A stepped-care programme that focuses on both depression and anxiety has never been
investigated in visually impaired older adults before. If the intervention is shown to be effective, this
study will result in an evidence based treatment programme to prevent depression or anxiety in patients
from low vision rehabilitation organisations. The pragmatic design of the study greatly enhances the
generalisability of the results. However, a possible limitation is the difficulty to investigate the contribution
of each individual step.
Trial registration: Identifier: NTR3296
Keywords: Low vision, Stepped-care, Older adults, Depression, Anxiety, PreventionBackground
According to the World Health Organisation, 285 million
people worldwide are visually impaired, of which 65% is
50 years or older [1]. Due to an aging population the
prevalence of visual impairment in developed countries
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that in 2020 this number will increase by 18% to 367,000
people [2].
Depression and anxiety symptoms are common in
visually impaired older adults. Recent studies suggested
that approximately one-third (range 22-42%) of visually
impaired older adults experience mild but clinically signifi-
cant depressive or anxiety symptoms, also known as
subthreshold depression or anxiety [3-6]. This is at least
twice as high as the prevalence in the general population
(10-15%) [7]. It is important to treat symptoms of depression
and anxiety in an early stage, because these are the mosttral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
van der Aa et al. BMC Psychiatry 2013, 13:209 Page 2 of 10
http://www.biomedcentral.com/1471-244X/13/209important predictors of developing a full-blown depressive
or anxiety disorder according to DSM-V criteria, such as
major depression, phobic disorders or generalized anxiety
disorder [8]. Studies suggested that loss of vision increases
the risk of depressive disorders [9,10].
Depressive and anxiety disorders decrease quality of life,
the ability to cope with daily life activities and even life
expectancy [11]. Even subthreshold manifestations of
depression and anxiety already have adverse consequences
for quality of life [7,12] and increase health care utilisation
[7]. Depression and anxiety often accompany disabling
diseases and aggravate existing disability [13]. In addition,
they may influence factors that are necessary for successful
rehabilitation, such as the ability to learn new tasks, pro-
cessing information and being oriented towards achieving
certain goals [5,14]. Depression and anxiety (both threshold
and subthreshold) often occur together, which causes even
more disability and distress in daily life [15-17]. Research
has shown that very few older adults experience only
depressive or anxiety disorders, without at least some
symptoms of the other [16,18].
Some studies have shown that interventions aimed at
preventing major depression and/or reducing subthreshold
symptoms of depression in the visually impaired can be
effective. Horowitz et al. (2005) found that variable low
vision rehabilitation services, such as counselling and
use of optical devices had a small positive effect on the
decline of depressive symptoms after two years [5,19]. In
another trial, with a follow-up period of six months,
Horowitz et al. (2006) showed that optical devices that
optimise residual vision, as apposed to adaptive aids
that involve learning new methods to compensate for
lost functions, had a positive effect on the course of
depressive symptoms [20]. Brody et al. (2006) found that a
self-management programme consisting of cognitive and
behavioural elements including health education and
enhancement of problem-solving skills, significantly
reduced depressive symptoms in people with age-related
macular degeneration (AMD) after six months [21]. Rees
et al. (2007) concluded that self-management programmes
for visually impaired adults are a promising way to help
address emotional distress [22]. Girdler et al. (2010)
also evaluated a self-management programme in visually
impaired older adults and reported significantly less depres-
sive symptoms at 12 weeks in participants who received the
programme as apposed to patients who received standard
visual rehabilitation services [23]. Rovner and Casten (2008)
found that problem solving treatment (PST), a short
behavioural treatment in which participants learn a new
method to address problems that interfere with everyday
functioning, prevented the onset of depressive disorders in
elderly with AMD after two months. However, after six
months there was no statistically significant difference in
depressive disorders between the intervention- and controlgroup [24]. To prevent the onset of depression on the long
term Rovner and Casten (2008) suggest to either continue
treatment in this high risk group after providing PST or
focus on preventive treatment for patients that show early
signs of depression [24]. Currently, Rovner and colleagues
are performing the Improving Function in Age-related
Macular Degeneration study (IF-AMD) in which they are
investigating the efficacy of PST compared to Supportive
Therapy in preventing depressive disorders [25]. Margrain
and colleagues are currently performing the Depression in
Visual Impairment Trial (DEPVIT) to reduce depressive
symptoms in visually impaired adults. They are comparing
three groups: one group that receives PST with additional
self-help materials, one group that is referred to the general
practitioner (GP) and one ‘waiting list control’ group [26].
These studies together suggest that low vision rehabili-
tation services, self-management programmes and PST
can be effective in addressing depressive symptoms and
depressive disorders among visually impaired people.
However, only a few studies evaluated the effectiveness
of such interventions and these studies were only
focused on depression and not on anxiety. Moreover,
economic evaluations of such interventions are completely
missing.
This project aims to design and test the (cost-)effective-
ness of a stepped-care programme to prevent the onset of
depressive and anxiety disorders in visually impaired older
adults (50 years and older) with subthreshold depression
and/or anxiety, in three low vision rehabilitation orga-
nisations in the Netherlands and Belgium. By reducing
symptoms of depression and anxiety, the intervention
is expected to positively influence (vision-related) quality
of life and adaptation to vision loss. It is an indicated
preventive intervention, aimed at persons who show
early signs of depression and/or anxiety but do not meet
the diagnostic criteria. The aim is to prevent or delay
the onset of major disorders and to reduce the severity
and shorten the duration of existing symptoms. Stepped-
care comprises different treatment components, such
as self-help and PST. The general idea is that if the
first, less intensive step does not lead to a reduction of
symptoms, then a patient moves to a next step which
consists of a more intensive and expensive treatment
type. This type of intervention is expected to be efficient,
because not all patients need the same type or intensity
of treatment [27]. Several randomised controlled trials
(RCTs) outside the field of low vision found that a
stepped-care intervention can be effective in addressing
depression and/or anxiety [28-33]. Furthermore, both the
Multidisciplinary guidelines for mental healthcare in
the Netherlands as the National Institute for Health
and Clinical Excellence (NICE) in the United Kingdom
recommend using a stepped-care model to address de-
pression in older adults [34,35].
1. Watchful
waiting
2. Guided self-
help
3. PST
4. Referral to
GP
Figure 1 Stepped-care programme.
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Development of a stepped-care programme for visually
impaired older adults
Evidence from previous studies
The first step in developing a new stepped-care programme
for visually impaired older adults was to search the litera-
ture for other stepped-care programmes and interventions
that were found to be effective in addressing depression
and anxiety.
Different RCTs outside the field of low vision found
that stepped-care programmes can be effective in reducing
depression and anxiety. Araya et al (2003) found that
a stepped-care programme for low-income women in
Santiago (Chile), consisting of a psycho-educational group
intervention and drug treatment, was effective in reducing
depression after 6 months [28]. Davidson et al. (2010)
found that a stepped-care programme, consisting of PST
and psychotherapy or medication, significantly decreased
depressive symptoms in patients with acute coronary
syndrome (ASC) and even improved the ASC prognosis
[29]. Patel et al. (2010) showed that a collaborative stepped-
care programme, consisting of psycho-education, psy-
chotherapy and medication, was effective in reducing
depressive and anxiety disorders in primary care [30].
Unutzer et al. (2008) found that a collaborative stepped-
care programme, consisting of PST and medication, was
cost-effective in reducing late-life depression in primary
care after 12 months, with total health care cost calculations
over a 4-year period [31]. Van ‘t Veer et al. (2009) showed
that a stepped-care programme for older adults in general
practice (75 years and older) was effective in preventing
depression and anxiety disorders after 12 months [32],
with effects sustaining even after 24 months [33]. This
programme consisted of a period of watchful waiting,
bibliotherapy (the use of reading materials as guidance),
PST and referral to the GP.
A recent systematic review concluded that cognitive
behavioural therapy (CBT) and PST can prevent the
development of depression and anxiety in patients with
subclinical manifestations of these disorders [36]. Both
treatment types help patients to acknowledge their symp-
toms and encourage them to switch to more active
self-management strategies [36]. Studies in the field of low
vision suggest that rehabilitation services, self-management
programmes and PST can be effective in addressing de-
pressive symptoms and depressive disorders among visually
impaired people [19-24]. Based on these findings an initial
protocol of the stepped-care programme for this study
was developed.
Focus groups
The second step in developing the protocol was to involve
health care workers and patient representatives of the
rehabilitation organisations. In this qualitative phase ofthe study, the initial protocol was discussed in one focus
group with 12 low vision health care workers (social
workers and psychologists) and two focus groups with
each 4 patient representatives (one in the Netherlands and
one in Belgium). Different aspects of the stepped-care
programme were discussed: intensity of guidance, type
of health care workers within rehabilitation organisations
who could offer guidance, accessibility of the intervention
and ways to stimulate patients to participate. Based on
these group meetings the initial protocol was adjusted.
After the adjustments, the protocol was sent to the same
health care workers and patient representatives. After some
revisions, the final content of the protocol was determined.Final protocol
Figure 1 shows the final stepped-care programme, which
consists of four consecutive steps. Each step takes approxi-
mately three months. Only if symptoms of depression and/
or anxiety persist, then patients move on to the next step.
Severity of symptoms is measured with the Epidemiologic
Studies Depression scale (CES-D) [37,38] and the Hospital
Anxiety and Depression Scale – Anxiety (HADS-A) [39].
Only if patients have a score of 16 or higher on the CES-D
and/or a score of 7 or higher on the HADS-A, then they
move on to the next step.Step 1: watchful waiting
In the first step, patients are followed to see if symptoms
of depression and/or anxiety recover spontaneously.
Patients are contacted by one of the researchers (first
author) at the beginning of this step to discuss their prob-
lems of depression and/or anxiety and give an explanation
of this first step of the programme. Patients are told that
they can contact the researcher during this period if
necessary, for example if symptoms of depression and/or
anxiety get worse or questions arise. In several studies it
was shown that symptoms of depression and anxiety may
recover spontaneously in this first period [36,40-42].
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When patients still have elevated scores on the CES-D
or HADS-A after 3 months, they receive the self-help
course “Glance at your Dip” (‘Blik op je Dip’ in Dutch).
This course is based on the course of Cuijpers et al. (2003)
(called ‘In de put, uit de put’ in Dutch) which was found
to be highly effective in preventing depressive and anxiety
disorders [43,44]. Techniques of CBT and PST are used in
this course.
Based on the focus groups, the self-help course was
rewritten and adapted specifically for patients with visual
impairments, e.g. by adding examples of problems people
often encounter in daily life due to their visual impairment.
The self-help course is offered in a written (large font), a
digital, an audio and Braille version. The self-help course
helps patients to address depressogenic and anxiogenic
thinking, improve social skills and increase pleasant activities
and relaxation. The aim is to help patients to cope better
with problems related to one’s symptoms of depression
and/or anxiety, such as vision loss.
Guidance in following the self-help course is provided
by occupational therapists who received a one-day training
(by the first and last author). Training consisted of infor-
mation about depression and anxiety, an explanation of
the stepped-care programme in total, the self-help course
and techniques to motivate patients in addressing their
problems.
In this second step of the programme, the trained
occupational therapist contacts the patient by telephone
and introduces the course. If the patient agrees, two face-
to-face contacts (at the rehabilitation organisation or at
home) take place. Subsequently, the occupational therapist
conducts several telephone calls and may schedule another
face-to-face contact to encourage patients to continue with
the course. The aim of the contacts is 1) to explore the
symptoms of depression and anxiety, 2) to reflect on these
symptoms by exploring everyday problems, 3) to create
awareness of the problems and the possibility to address
them, 4) to encourage participants to complete/continue
the self-help course. The first two goals help to establish
a working relationship between the patient and the oc-
cupational therapist. The second two goals help patients
recognise their problems and the possibility to address
them even in an early stage of the complaints.
Older adults who feel depressed often find it difficult to
find the energy and motivation to work on their problems.
Therefore, techniques of Motivational Interviewing (express
empathy, roll with resistance not fight it, support self-
efficacy) are used to stimulate this. Research shows that
these techniques can be effective in stimulating patients in
seeking and accepting help and making changes in their
behaviour [45].
The researchers (first author; social worker and last
author; psychologist), who developed the self-help course,monitor the execution of the intervention by keeping
in close contact with the occupational therapists by
telephone and e-mail (at least one contact every two weeks)
and by organising a peer group meeting to share experi-
ences and learn from each other. Additionally, occupational
therapists and patients are asked to evaluate the self-help
course on a written evaluation form. They are asked what
they think about the intervention, about the guidance that
was given and about the results.
Step 3: problem solving treatment (PST)
When patients still have elevated scores on the CES-D or
HADS-A after step 2, they receive PST by a trained social
worker or psychologist at the rehabilitation organisation.
PST is a short evidence-based behavioural treatment
which helps patients to regain control of their life, which
reduces feelings of depression and anxiety [46]. With PST,
the patient learns to identify and address problems that
interfere with everyday functioning and lead to feelings of
depression and anxiety by means of 7 different steps: 1)
clarifying the problem, 2) establishing a realistic goal to
address the problem, 3) generating multiple solution
alternatives, 4) exploring the pros and cons for each
possible solution, 5) choosing the preferred solution, 6)
identifying the specific steps needed to carry out the
solution, 7) after trying to implement the solution, in the
next meeting the process will be evaluated.
Social workers and psychologists received a one-day
training in two groups by a qualified PST trainer and
supervisor (psychologist, PhD) with experience in stepped-
care. Information about the techniques and different steps
of PST was given and was practiced in role-plays. After
that, all social workers and psychologists piloted their
learned skills on a patient that did not participate in this
study.
In this third step of the programme the social worker
or psychologist contacts the patient by telephone and
introduces PST. If the patient agrees, subsequently a
maximum of seven face-to-face contacts (at the rehabilita-
tion organisation or at home) take place in which the stages
of PST are explained and applied to problems encountered
in daily life. Patients choose their own problems to work on
and are able to use a list (large font) of potential problems
(related to physical-, psychological-, practical- and social
functioning) to help them think of problems to address.
Furthermore, a CD with the different steps of PST is given
to patients as a reminder for practising at home in between
the meetings.
To secure fidelity with the intervention, a qualified PST
trainer and supervisor (psychologist, PhD) guides social
workers and psychologists in performing PST, by means
of telephone calls and e-mail. In addition, a peer group
meeting is organised to share experiences and learn from
each other. Two sessions per patient are audio-taped to
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and researcher (first author) review these tapes. Addition-
ally, social workers, psychologists and patients are asked
to evaluate the process. They are asked what they think
about the intervention, about the guidance that was given
and about the results.Step 4: referral to general practitioner (GP)
When symptoms persist, patients are referred to their
GP to discuss further (more intensive) treatment and to
discuss the use of medication. GPs are the so called
‘gate-keepers’ for all (mental) health care facilities in the
Netherlands. They can refer patients to other care providers
or may prescribe medication. If patients are diagnosed
with a depressive or anxiety disorder during the study, as
measured with the Mini International Neuropsychiatric
Interview (MINI) [47], they are directly referred to their
GP to discuss further treatment and medication.
Not all patients in the intervention group complete all
phases of the stepped-care intervention, because treatment
is only initiated if symptoms of depression and/or anxiety
remain elevated. Patients who recover enter a period of
‘watchful waiting’. When elevated symptom levels again
indicate a need for treatment, the following step of the
intervention is initiated.Design of a randomised controlled trial (RCT)
The design of the study is a two-armed multicentre
international RCT, conducted at two rehabilitation orga-
nisations in the Netherlands and one in Belgium, to
evaluate the (cost-) effectiveness of the new stepped-care
programme to prevent depression and anxiety in visually
impaired older adults. The study protocol was approved
by the Medical Ethics Committee of the VU University
Medical Centre in Amsterdam, the Netherlands and the
University Hospital Leuven in Belgium. It is conducted
according to the principles of the Declaration of Helsinki.
Patients are fully informed about the study and give
written informed consent. They are allowed to withdraw
this consent at any time during the study.Setting
Low vision rehabilitation organisations in the Netherlands
and Belgium operate at the interface between health care
and social care. They support people with vision loss by
training them to make use of their residual vision and
cope with everyday problems aimed at home-, leisure-,
school-, work or other activities and participation issues.
That is why a programme to address depression and
anxiety, in addition to usual visual rehabilitation care, fits
well within this setting.Recruitment
The invitation of patients (approximately N = 3000) is done
in four waves, with three months in between (September
2012, December 2012, March 2013 and June 2013). This
is to avoid the need for all patients having to be treated at
the same time. Patients from the low vision rehabilitation
organisations who are 50 years or older receive an informa-
tion letter and an informed consent form. After they
give written consent to participate, they are screened
for eligibility.
Participants
Visually impaired older adults with subthreshold depression
or anxiety, but no actual depression or anxiety disorder
according to the DSM IV, with sufficient knowledge of
the Dutch language, without severely impaired cognitive
functioning and capable to give informed consent are
eligible to participate. Depressive symptoms are measured
with the Centre for Epidemiologic Studies Depression scale
(CES-D) [37,38] and anxiety symptoms with the Hospital
Anxiety and Depression Scale – Anxiety (HADS-A) [39].
Visually impaired older adults who have a score of 16 or
higher on the CES-D or a score of 7 or higher on the
HADS-A are eligible to participate. If participants have a
depressive or anxiety disorders according to the DSM IV
as measured with the Mini International Neuropsychiatric
Interview (MINI) they are excluded from the study [47].
Cognitive functioning is evaluated by means of a six-item
screener. This is a modified version of the Mini-mental
state examination (MMSE), with a score of 3 or more
errors indicating cognitive problems [48]. Patients who
have no complaints and patients with a depressive or
anxiety disorder after the first screening are not randomised
but are followed in this study to see how symptoms develop
over time.
Randomisation
Patients are randomly assigned to either the intervention
group (stepped-care programme) or the control group
(usual care). Randomisation is performed using a com-
puter-generated allocation scheme based on blocks of two,
stratified by 17 different locations of the three low vision
rehabilitation organisations in both the Netherlands and
Belgium. Usual care consists of the support low vision
rehabilitation organisations normally offer to visually
impaired older adults and/or care that is received by other
providers on the initiative of patients.
Masking
Masking of participants and therapists is not possible due
to the nature of the intervention. However, the principal
investigator and the research assistants are masked until
after the primary outcomes of the study are analysed.
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In total seven measurements take place. One at baseline
and thereafter at every step of the intervention (at 3, 6, 9
and 12 months) and at follow-up (at 18 and 24 months).
Outcome measures are obtained over the phone by masked
research assistants. These assistants are trained (by the
first author) to follow a predetermined protocol. The first
interview takes approximately 45 minutes; the next
interviews take approximately 30 minutes. In Figure 2 an
overview of the design is presented.
Outcomes
The primary outcome of this study is the incidence of
depressive (major depression and dysthymia) or anxiety
disorders (panic disorder, agoraphobia, social phobia and
generalised anxiety disorder) as measured with the MiniVisually impaired
(50+) are invited (
Assessment for el
D, HADS-A, MIN
Randomisation (n
Allocation to intervention group 
(n ≈ 115)
Received intervention (n=..)
Did not receive intervention (n=..)
After 3 months
Loss to follow-up (n=..)
Discontinued intervention (n=..) 
After 6 months
Loss to follow-up (n=..)
Discontinued intervention (n=..) 
After 9 months
Loss to follow-up (n=..)
Discontinued intervention (n=..) 
After 12 months
Loss to follow-up (n=..)
Discontinued intervention (n=..) 
After 18 months
Loss to follow-up (n=..)
Discontinued intervention (n=..) 
After 24 months
Loss to follow-up (n=..)
Discontinued intervention (n=..) 
Analyse (n=..)
Excluded from analysis (n=..)
Figure 2 Overview of the RCT design.International Neuropsychiatric Interview (MINI) [47], using
the electronic version MiniManager 2.0 (de Beurs, Leiden
University Medical Centre). Secondary outcome measures
are subthreshold depression measured with the Centre for
Epidemiologic Studies Depression scale (CES-D) [37,38]
and subthreshold anxiety measured with the Hospital
Anxiety and Depression Scale – Anxiety (HADS-A) [39].
Other secondary outcome measures are vision related
quality of life as measured with the Low Vision Quality
Of Life questionnaire (LVQOL) [49,50] and health related
quality of life measured with the EuroQol-5 Dimensions
(EQ-5D) [51]. Adaptation to vision loss is measured with
the Adaptation to age-related Vision Loss (AVL) question-
naire [52] and perceived need for care is measured with
the Perceived Need for Care Questionnaire (PNCQ) [53].
For the process-evaluation the Dutch Mental Healthcare older adults 
n ≈ 3000)
igibility (CES-
I) (n ≈ 900)
 ≈ 230)
Exclusion:
Refused (n =..)
Other reasons (n=..)
Exclusion:
Not meeting criteria 
(n=..)
Refused (n =..)
Other reasons (n=..)
Allocation to control group 
(n ≈ 115)
After 3 months
Loss to follow-up (n=..)
After 6 months
Loss to follow-up (n=..)
After 9 months
Loss to follow-up (n=..)
After 12 months
Loss to follow-up (n=..)
After 18 months
Loss to follow-up (n=..)
After 24 months
Loss to follow-up (n=..)
Analyse (n=..)
Excluded from analysis (n=..)
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the different steps of the stepped-care programme [54].
For the cost-evaluation the Trimbos/iMTA questionnaire
for Costs associated with Psychiatric illness (TicP) is used
to measure health care utilisation [55] and the Short Form
Health and Labour Questionnaire (SF-HLQ) to measure
absenteeism and presenteeism from paid and unpaid work
[56]. Standard costs for health care utilization from the
Dutch costing guidelines are used [57]. Medication use is
valued using prices of the Royal Dutch Society of Pharmacy.
Productivity losses will be valued using the Friction Cost
Approach. In Table 1 the different outcome measures are
presented per follow-up measurement.
Sample size
The power calculation is based on the study of van Van
‘t Veer et al. 2009 in which a comparable stepped-care
programme was tested in older adults [32]. Results form
this study showed that over a period of two years approxi-
mately 40% of older adults in the control group, which
was not depressed at baseline, became depressed during
this study, versus 20% of older adults in the intervention
group. Therefore, it is expected that the programme will
lead to a reduction of depressive and anxiety disorders
of 50% (approximately 20% versus 40%). Based on a
power of 85%, a significance level of 0.05 (two-sided)
and a drop-out rate of 20%, 115 patients are needed in each
group to demonstrate an effect size of 0.50. Approximately
3000 visually impaired patients (of 50 years and older)
of one of the rehabilitation organisations, are invited to
participate in the screening for this study. We expect
that approximately 30% is willing to cooperate, resulting
in 900 patients who can be screened for symptoms of
depression and anxiety with the CES-D and HADS-A andTable 1 Outcome measures, instruments and assessments
Steps T0 T1
3 m
Primary Outcome
Depression or anxiety disorder (MINI) [47] x x
Secondary Outcomes
Subthreshold depression (CES-D) [37,38] x x
Subthreshold anxiety (HADS-A) [39] x x
Six item screener [48] x
Vision related quality of life (LVQOL) [49,50] x
Health related quality of life (EQ5D) [51] x
Adaptation to age-related Vision Loss (AVL) [52] x
Perceived need for care (PCNQ) [53] x x
Patient satisfaction (DMH thermometer) [54] x
Health care utilisation (Tic-P) [55] x
Health and labour (SFHLQ) [56] xon depressive or anxiety disorders with the MINI, by
means of a telephone interview. This will result in approxi-
mately 230 eligible patients.
Statistical analysis
The analyses are based on the intention-to-treat principle.
Statistical analyses are performed using SPSS 20. First,
descriptive statistics of baseline characteristics are compared
to check whether randomisation is successful in generating
two similar groups. Survival analyses and mixed modelling
is then used to compare the treatment and control group.
All available data in all measurement cycles are used to
estimate the longitudinal trial outcomes at 3, 6, 9, 12, 18
and 24 months after baseline.
For the economic evaluation multiple imputation is used
to impute missing data. Bias-corrected and accelerated
bootstrapping with 5000 replications is used to estimate
95% confidence intervals around the mean difference
in total costs between the treatment and control group.
Incremental cost-effectiveness ratios (ICERs) are calculated.
Bootstrapping is used to estimate the uncertainty surround-
ing the ICERs. Cost-effectiveness acceptability curves and
net monetary benefits are also estimated.
Discussion
Depression and anxiety symptoms are common in visually
impaired older adults and this elderly group will only grow
in the future because of the ageing of the population. It is
crucial to treat depressive and anxiety symptoms, because
they are the most important predictors of developing a
full-blown depressive or anxiety disorder. However, the
evidence for preventive interventions has received little
attention in the field of low vision. This study aims to
investigate an indicated preventive intervention to preventT2 T3 T4 T5 T6
6 m 9 m 12 m 18 m 24 m
x x x x x
x x x x x
x x x x x
x x
x x
x x
x x x x x
x x x
x x x
x x x
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that show early signs of the disorders.
Strengths
This study is innovative because the (cost-)effectiveness
of a stepped-care programme to prevent depression and
anxiety has never been tested in a visually impaired
population before. Additionally, the programme is based
on successful stepped-care interventions for older adults
in the general population [31-33] and other effective
components of preventive interventions in the field of
low vision [21,24]. Another strength of this study is that
the treatment is aimed at preventing both depression and
anxiety. The few studies, that investigated interventions to
reduce depression in the field of low vision, did not take
anxiety into account while several other studies suggest
that anxiety is as important a problem for visually im-
paired older adults as depression is [58,59]. Moreover,
this stepped-care programme is embedded within rehabili-
tation organisations for the visually impaired, where health
care workers with the specific expertise of working with
visually impaired older adults can offer treatment to reduce
symptoms of depression and anxiety in addition to usual
visual rehabilitation care. It is very important to address
depression and anxiety in this setting because depression
and anxiety seriously complicate successful rehabilitation.
By letting healthcare workers from the rehabilitation orga-
nisations provide the treatment themselves, continuation
of the intervention after the end of this trial is highly im-
proved. This pragmatic design enhances the generalisability
of this study.
Challenges
The recruitment of participants is likely to be difficult
because it is a challenging subject for a very frail population
(older adults, visually impaired and symptoms of depres-
sion and/or anxiety). To address this challenge and to
allow patients to receive oral information about the study,
all patients (approximately N = 3000) who receive written
patient information on the study are approached by tele-
phone by the rehabilitation organisations. Still, drop-out
rates may be high because of the vulnerability of the popu-
lation (sickness, death) and because of the quantity and
types of questions that are asked. The way in which these
questions are asked may be confronting and cause feelings
of sadness or worry. Patients might also have low motiv-
ation to comply to the different steps of the programme,
because of their depressive state [60]. Therapist support
will be used to stimulate their motivation [45]. Another
challenge is the possibility of contamination: health care
workers might give more attention to problems of depres-
sion and anxiety because of their newly learned skills to
provide support for these problems to patients outside the
intervention group. Therefore, it is stressed to health careworkers to not offer treatment according to the stepped-
care programme to patients outside the intervention
group. Finally, it may be difficult to weigh the specific
contributions of the various steps in the stepped-care
programme, because of the pragmatic design of the study.
Not all patients of the intervention group follow the same
steps of the programme.
Conclusion
The importance and strengths of this study outweigh the
challenges. The development and research of the (cost-)
effectiveness of a stepped-care programme to prevent
depressive and anxiety disorders in visually impaired older
adults is of the greatest importance.
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